BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2805261)

  • 1. The effect of diltiazem on coronary flow reserve in humans.
    Rossen JD; Simonetti I; Marcus ML; Braun P; Winniford MD
    Circulation; 1989 Nov; 80(5):1240-6. PubMed ID: 2805261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of increases in heart rate and arterial pressure on coronary flow reserve in humans.
    Rossen JD; Winniford MD
    J Am Coll Cardiol; 1993 Feb; 21(2):343-8. PubMed ID: 8425996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary hemodynamics and coronary flow reserve after intracoronary diltiazem in humans.
    Vrolix MC; Sionis D; Piessens JH; Van Lierde J; Willems JL; De Geest H
    Am J Cardiol; 1991 Dec; 68(17):1633-7. PubMed ID: 1746465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenosine on human coronary arterial circulation.
    Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD
    Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diltiazem on coronary flow reserve in patients with microvascular angina.
    Sütsch G; Oechslin E; Mayer I; Hess OM
    Int J Cardiol; 1995 Nov; 52(2):135-43. PubMed ID: 8749873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in human coronary flow reserve after administration of intracoronary diltiazem.
    Vrolix MC; Sionis D; Piessens J; Van Lierde J; Willems JL; De Geest H
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S64-7. PubMed ID: 1725547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease.
    Kern MJ; Deligonul U; Tatineni S; Serota H; Aguirre F; Hilton TC
    J Am Coll Cardiol; 1991 Sep; 18(3):718-29. PubMed ID: 1869735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
    Rossen JD; Nahser PJ; Oskarsson H; Brown RE; Winniford MD
    Coron Artery Dis; 1996 Jun; 7(6):479-84. PubMed ID: 8889365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.
    Nichols AJ; Koster PF; Ohlstein EH
    Br J Pharmacol; 1990 Mar; 99(3):597-601. PubMed ID: 2184913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiischemic therapy on coronary flow reserve and the pressure-maximal coronary flow relationship in anesthetized swine.
    McFalls EO; Duncker DJ; Sassen LM; Gho BC; Verdouw PD
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):827-36. PubMed ID: 1725894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary hemodynamics following intravenous or intracoronary injection of diltiazem in man.
    Bertrand ME; Dupuis BA; Lablanche JM; Tilmant PY; Thieuleux FA
    J Cardiovasc Pharmacol; 1982; 4(5):695-9. PubMed ID: 6182397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease.
    Joyal M; Cremer KF; Pieper JA; Feldman RL; Pepine CJ
    Am J Cardiol; 1985 Sep; 56(7):413-7. PubMed ID: 4036821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacing-induced ischemia.
    Grover GJ; Parham CS
    Eur J Pharmacol; 1987 Nov; 143(1):109-17. PubMed ID: 3691645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is coronary flow reserve in response to papaverine really normal in syndrome X?
    Chauhan A; Mullins PA; Petch MC; Schofield PM
    Circulation; 1994 May; 89(5):1998-2004. PubMed ID: 8181123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload.
    McGinn AL; White CW; Wilson RF
    Circulation; 1990 Apr; 81(4):1319-30. PubMed ID: 2317912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.
    Wilson RF; White CW
    Circulation; 1986 Mar; 73(3):444-51. PubMed ID: 3948354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various doses of intracoronary diltiazem on coronary resistance vessels in humans.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Ueda A; Kurisu S
    Jpn Circ J; 1995 Dec; 59(12):790-8. PubMed ID: 8788370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.